These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4408121)

  • 1. [Tests of somatotropin reserve in obesity: response of GH to stimulation with L-DOPA and L-arginine].
    D'Alessandro B; Bellastella A; Esposito V; Gasbarro R
    Folia Endocrinol; 1974 Aug; 27(4):381-9. PubMed ID: 4408121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obesity and the somatotropic hormone. I. Somatotropin secretion in obesity].
    Giordano G; Foppiani E; Minuto F; Marugo M
    Folia Endocrinol; 1974 Aug; 27(4):339-68. PubMed ID: 4408078
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone responses to hypoglycaemia and arginine tests in hyperthyroid and hypothyroid patients.
    Neri V; Ambrosi B; Beck-Peccoz P; Faglia G
    Folia Endocrinol; 1973 Apr; 26(2):102-9. PubMed ID: 4580539
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of somatotropin and corticotropin function with radioimmunological methods in primary hypothyroidism].
    Lombardi G; Aroldi A; Minozzi M; Oliver C; Vague P; Faggiano M; Criscuolo T
    Folia Endocrinol; 1973 Dec; 26(6):460-75. PubMed ID: 4359633
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-dopa and somatotropin secretion in humans].
    Giordano G; Marugo M; Minuto F; Barreca T; Foppiani E
    Folia Endocrinol; 1973 Dec; 26(6):523-37. PubMed ID: 4801262
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Levodopa and L-arginine to test GH release in obesity.
    D'Allessandro B; Bellastella A; Esposito V; Gasbarro R
    N Engl J Med; 1974 Mar; 290(10):575. PubMed ID: 4811111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental modifications in the gluco-lipidic and growth hormone behavior after arginine infusion in human obesity].
    Durán S; Maranõn A; Gómez J; López F; Romero E
    Rev Clin Esp; 1973 Apr; 129(2):129-34. PubMed ID: 4709843
    [No Abstract]   [Full Text] [Related]  

  • 8. [Exploration of the hypothalamo-pituitary-somatotropic axis].
    Franchimont P; Legros JJ; Schaub JC
    Rev Fr Endocrinol Clin; 1970; 11(2):105-19. PubMed ID: 5481838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Growth hormone in obesity].
    Oliver C; Jaquet P; Vague P; Martin-Laval C; Argemi B; Djion R
    Rev Fr Endocrinol Clin; 1971; 12(5):425-32. PubMed ID: 4949282
    [No Abstract]   [Full Text] [Related]  

  • 10. [Growth hormone stimulation with L. Dopa].
    Elkaïm R; Halimi S; Guidicelli C; Agnius-Delord C; Hadjian A; Perret J; Micoud M
    Nouv Presse Med; 1972 Mar; 1(10):675-7. PubMed ID: 4553974
    [No Abstract]   [Full Text] [Related]  

  • 11. HGH radioimmunoassay. Glucagon and L-dopa stimulation tests.
    Troncone L; Martino F; Barbarino A; Velardo A
    J Nucl Biol Med; 1973; 17(2):84-91. PubMed ID: 4754436
    [No Abstract]   [Full Text] [Related]  

  • 12. A preview of growth hormone stimulation tests in children.
    Frasier SD
    Pediatrics; 1974 Jun; 53(6):929-37. PubMed ID: 4364973
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothalamo-pituitary function in Pickwickian syndrome.
    Smirne S; Reschini E; Giustina G
    Bull Physiopathol Respir (Nancy); 1972; 8(5):1021-8. PubMed ID: 4657861
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood serum cortisol, insulin and somatotropin concentration in children with hypothalamo-hypophyseal insufficiency].
    Rybakowa M; Pleti M; Sołtysik-Wilk E; Jaśkiewicz J
    Endokrynol Pol; 1979; 30(6):549-55. PubMed ID: 231516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial findings on the behavior of the hypophyseal somatotropic hormone in essential obesity].
    Scavo D; Sereno L; Recchia O; Conti C
    Folia Endocrinol; 1966 Apr; 19(2):152-60. PubMed ID: 6012692
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone response to L-dopa in the thinned obese.
    Laurian L; Oberman Z; Hoerer E; Wiznitzer T; Harell A
    Isr J Med Sci; 1982 May; 18(5):625-9. PubMed ID: 7096047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional exploration of the somatotropic activity of the pituitary gland by means of arginine-insulin load. Studies on "harmonic" nanisms with special reference to patients with intermedial somatotropin values].
    Gaburro D; Zoppi G
    Minerva Pediatr; 1976 May; 28(17):1035-41. PubMed ID: 1012171
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and growth hormone response in induced hypoglycaemia in obese patients.
    Micić DD; Djurić DS; Manojlović DL; Dragasević MM
    Endocrinologie; 1981; 19(2):137-41. PubMed ID: 7020062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.